Trevor Nicholls has joined Santa Clara, Calif.-based Affymetrix as chief commercial officer for global operations. In this newly created position, he will lead global sales, marketing, and manufacturing operations.
Prior to joining Affymetrix, Nicholls was the CEO and founder of Oxagen, a clinical genomics company spun out of Oxford University. He also served previously as the commercial director of the life science business of Amersham International where he managed the worldwide business. Before that, he was a management consultant with McKinsey & Company. Nicholls holds a BS and a DPhil in biochemistry from the University of York.
David Bartel, Joan Brugge, Michael Greenberg, David Sabatini, Roger Tsien, Thomas Tuschl, Marc Vidal, Richard Young, and Phillip Zamore are the founding members of the scientific advisory board for cellular array company Akceli of Cambridge, Mass. Bartel is an associate professor of biology and Young a professor at MIT; Brugge is a cell biology professor and Greenberg a neurology and neurobiology professor at Harvard Medical School; Sabatini is a Whitehead Institute fellow and a co-founder of Akceli; Tsien is a professor of pharmacology, chemistry, and biochemistry at the University of California, San Diego; Tuschl is a group leader at the Max-Planck-Institute for Biophysical Chemistry in Göttingen, Germany; Vidal is an assistant professor of genetics at the Dana Farber Cancer Institute; and Zamore is an assistant professor of biochemistry and molecular biology at the University of Massachusetts Medical School.